Literature DB >> 7112336

Spontaneous mutant of Blastomyces dermatitidis attenuated in virulence for mice.

C Brass, C M Volkmann, D E Philpott, H P Klein, C J Halde, D A Stevens.   

Abstract

A spontaneous mutation occurred in cultures of a virulent strain of Blastomyces dermatitidis during serial passage at 35-37 degrees C. The mutant strain was shown to be 10,000-fold less virulent for mice than the parent strain, and this was independent of the challenge dose, the age of the challenged host, and the route of challenge (although attenuation was greater for pulmonary than for peritoneal challenge). The mutant grows as well as the parent in fungal media or in the presence of murine substrates. Studies of the chronology of pulmonary infection indicate the mutation affects an early event (first week after challenge) in establishment of infection and interaction with host defenses. Scanning electron microscopy showed that the mutant lacks deep irregular surface ridges and grooves present in the parent. It had increased resistance to crystal violet in vitro, increased susceptibility to bile, and could hydrolyze esculin. The latter findings are of interest because they place the mutant in an intermediate position with respect to these properties between the virulent parent and a previously studied avirulent strain. Lipid analyses indicated a marked increase in fatty acids in the mutant. Studies of four B. dermatitidis strains have also associated increasing palmitic acid and phospholipid content with increasing virulence.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7112336

Source DB:  PubMed          Journal:  Sabouraudia        ISSN: 0036-2174


  17 in total

1.  Alterations in the pathogenicity of one Paracoccidioides brasiliensis isolate do not correlative with its in vitro growth.

Authors:  S S Kashino; L M Singer-Vermes; V L Calich; E Burger
Journal:  Mycopathologia       Date:  1990-09       Impact factor: 2.574

2.  Mechanisms of fungal pathogenicity: correlation of virulence in vivo, susceptibility to killing by polymorphonuclear neutrophils in vitro, and neutrophil superoxide anion induction among Blastomyces dermatitidis isolates.

Authors:  C J Morrison; D A Stevens
Journal:  Infect Immun       Date:  1991-08       Impact factor: 3.441

Review 3.  Inflammasomes and adaptive immune responses.

Authors:  Katherine A Deets; Russell E Vance
Journal:  Nat Immunol       Date:  2021-02-18       Impact factor: 25.606

4.  Fungal-strain-dependent alterations in the time course and mortality of chronic murine pulmonary blastomycosis.

Authors:  S A Moser; P J Koker; J E Williams
Journal:  Infect Immun       Date:  1988-01       Impact factor: 3.441

5.  Mutation of the WI-1 gene yields an attenuated blastomyces dermatitidis strain that induces host resistance.

Authors:  M Wüthrich; H I Filutowicz; B S Klein
Journal:  J Clin Invest       Date:  2000-12       Impact factor: 14.808

Review 6.  Virulence factors of medically important fungi.

Authors:  L H Hogan; B S Klein; S M Levitz
Journal:  Clin Microbiol Rev       Date:  1996-10       Impact factor: 26.132

7.  Altered expression of surface alpha-1,3-glucan in genetically related strains of Blastomyces dermatitidis that differ in virulence.

Authors:  L H Hogan; B S Klein
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

8.  Altered expression of surface protein WI-1 in genetically related strains of Blastomyces dermatitidis that differ in virulence regulates recognition of yeasts by human macrophages.

Authors:  B S Klein; S Chaturvedi; L H Hogan; J M Jones; S L Newman
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

9.  Susceptibility of Blastomyces dermatitidis strains to products of oxidative metabolism.

Authors:  A M Sugar; R S Chahal; E Brummer; D A Stevens
Journal:  Infect Immun       Date:  1983-09       Impact factor: 3.441

10.  Immunogenicity and protective efficacy of the WI-1 adhesin of Blastomyces dermatitidis.

Authors:  M Wüthrich; W L Chang; B S Klein
Journal:  Infect Immun       Date:  1998-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.